Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early Alzheimer's disease.
about
Homogeneous Biosensing Based on Magnetic Particle LabelsA systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's diseaseBlood-Based Proteomic Biomarkers of Alzheimer's Disease PathologyBody fluid biomarkers in Alzheimer's diseaseThe potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's diseaseEstimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.Hippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer's disease.Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles.Plasma tau in Alzheimer disease.Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease.Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer's Disease.Repetitive head impact exposure and later-life plasma total tau in former National Football League players.Plasma Tau Levels in Cognitively Normal Middle-Aged and Older Adults.On comparing 2 correlated C indices with censored survival data.A Review of Biomarkers for Alzheimer's Disease in Down SyndromeIncreasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data.Plasma α-synuclein predicts cognitive decline in Parkinson's disease.Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress.Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer's Dementia: Findings in Two Cohorts.Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseasesTau plasma levels in subjective cognitive decline: Results from the DELCODE study.Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome.Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.Brain Amyloid-β Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease.Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.Tubulin and Tau: Possible targets for diagnosis of Parkinson's and Alzheimer's diseases.Plasma Biomarkers Differentiate Parkinson's Disease From Atypical Parkinsonism Syndromes.Tau in neurodegenerative disease.
P2860
Q26747505-06B134DB-490F-4442-A37D-3F7875BD10D7Q26771808-B7D946EB-4C7B-4126-8D2D-F860FDD6E81EQ26774743-D44E2D2E-FD28-4D96-A654-D654A364C465Q26830098-5C394EEF-7B07-472A-A339-C13FFA03A833Q26853347-B167EDED-9E30-4256-89D1-A8754B124100Q36086092-817DA37A-A0B8-4573-B740-C2AEF6E3E823Q36305905-8117CFAB-1620-4FF7-8D4A-5C834D5D10C8Q36982173-01A80DC8-B028-43E6-A738-092B3327611EQ37384690-940F8A69-A653-4B84-9701-FEAE5A0A04DCQ37403102-462735A0-C738-451D-A310-EEEA765DF1BEQ37588576-387A287D-2B2E-436B-8534-D13F36F36C81Q37645272-FF469364-5B16-46B4-B70F-788153B7029EQ37681181-A4646D27-1992-4B0B-84D1-F81964DE30A3Q38652465-5139D880-CC29-472E-A362-32164EABBB5BQ38653406-5FD4D92F-2325-4202-92E4-A53A4416DED5Q38666998-597EF0CB-4407-4265-9A1E-C84378D5CF3EQ38760749-62B1F71E-C793-4151-9D37-861AC5E3BBFDQ38980003-85290F3F-3111-428D-88A1-B1286C0B0399Q39451605-FA61F4C7-3E6D-469F-AD23-125EA2069E2CQ39451611-2C465B0E-7F45-409C-A6F7-CAE05F1F4167Q40129154-8C7D7B4D-BD3A-4820-8979-07062CA7321BQ41097447-5ED2B802-292C-4FF1-ADA8-189BFEBBA0A0Q41518367-C5E9BE4A-9428-44EC-87DC-A1A11733CD2EQ41534154-DD5530EA-7BAA-408B-9702-AF4F6C272DA9Q41600844-D10AEC93-C872-47AF-B020-C24D13CAE1AFQ48409075-50B47F7A-B361-4E8E-A959-AB8B211F4972Q50655925-F1ABA350-97D1-4F81-900B-33E51B5B3B85Q52594155-6D0060B2-65F5-4386-9EB7-384F0B03DD14Q54980572-F759D428-949C-4638-B032-372BE2E6AF4EQ55110559-0EB2033C-2C82-46E8-9671-373A9711EC97Q55421746-2E17CF22-40F5-49B3-8D05-CFEAA74492B6
P2860
Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early Alzheimer's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Plasma tau as a window to the ...... and early Alzheimer's disease.
@en
Plasma tau as a window to the ...... and early Alzheimer's disease.
@nl
type
label
Plasma tau as a window to the ...... and early Alzheimer's disease.
@en
Plasma tau as a window to the ...... and early Alzheimer's disease.
@nl
prefLabel
Plasma tau as a window to the ...... and early Alzheimer's disease.
@en
Plasma tau as a window to the ...... and early Alzheimer's disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Plasma tau as a window to the ...... and early Alzheimer's disease
@en
P2093
Fan-Pei Gloria Yang
Herng-Er Horng
Jia-Chun Rare Chen
Mau-Sun Hua
Shieh-Yueh Yang
Ta-Fu Chen
Tien-Wen Tseng
Ya-Fang Chen
P2860
P304
P356
10.1002/HBM.22390
P577
2013-10-15T00:00:00Z